4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-320992
Director acquired 9,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| THEUER CHARLES Director | 2025-12-12 | Option exercise | +9,333 | $1.14 | $10,640 | 41,684 | D |
| Derivatives | |||||||
| THEUER CHARLES Director | 2025-12-12 | Option exercise · Stock Option (Right to Buy) | −9,333 | 0 | D | ||
Loading xslF345X05/ownership.xml…